We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Is Patterson Cos. (PDCO) Down 11% Since Last Earnings Report?
Read MoreHide Full Article
A month has gone by since the last earnings report for Patterson Cos. (PDCO - Free Report) . Shares have lost about 11% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Patterson Cos. due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
Patterson Companies Q2 Earnings Beat, Animal Health Up
Patterson Companies reported adjusted earnings of 39 cents per share in the second quarter of fiscal 2019, beating the Zacks Consensus Estimate of 36 cents. Earnings however fell 23.5% year over year.
Net sales in the quarter were $1.40 billion, up 1.4% year over year, missing the Zacks Consensus Estimate by a slight 0.01%.
Segmental Analysis
The company currently distributes products through subsidiaries — Patterson Dental and Patterson Animal Health.
Dental Segment
This segment provides a virtually complete range of consumable dental products, equipment, software, turnkey digital solutions and value-added services to dentists as well as laboratories throughout North America.
In the second quarter, dental sales (39% of total sales) declined 2% year over year to approximately $542.5 million.
Dental Consumable
Sales in the sub-segment were $303.8 million, down 2.4% year over year.
Dental Equipment & Software
Sales in the segment fell 1.1% on a year-over-year basis to $167.7 million.
Other
This segment comprises technical service, parts and labor, software support services as well as office supplies. Sales in the segment declined 2.6% on a year-over-year basis to $71 million.
Animal Health Segment
This segment is a leading distributor of veterinary supplies to clinics, public and private institutions and shelters across the United States.
Coming to the second-quarter performance of the platform (61% of total sales), sales increased almost 3.9% on a year-over-year basis to $855.4 million.
Corporate
Sales at the segment were $6.83 million, down 19.9% year over year.
Gross Margin Analysis
Gross profit in the reported quarter was $295.1 million, down 6.5% year over year. As a percentage of revenues, gross margin contracted 180 basis points (bps) to 21% in the second quarter.
Operating expenses in the reported quarter totaled $253.9 million, up 4% on a year-over-year basis.
Guidance
For fiscal 2019, Patterson Companies has retained its guidance. Notably, earnings per share are expected in the range of $1.40 to $1.50.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in fresh estimates.
VGM Scores
At this time, Patterson Cos. has a subpar Growth Score of D, however its Momentum Score is doing a lot better with a B. Charting a somewhat similar path, the stock was allocated a grade of A on the value side, putting it in the top 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of this revision indicates a downward shift. Notably, Patterson Cos. has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why Is Patterson Cos. (PDCO) Down 11% Since Last Earnings Report?
A month has gone by since the last earnings report for Patterson Cos. (PDCO - Free Report) . Shares have lost about 11% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Patterson Cos. due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
Patterson Companies Q2 Earnings Beat, Animal Health Up
Patterson Companies reported adjusted earnings of 39 cents per share in the second quarter of fiscal 2019, beating the Zacks Consensus Estimate of 36 cents. Earnings however fell 23.5% year over year.
Net sales in the quarter were $1.40 billion, up 1.4% year over year, missing the Zacks Consensus Estimate by a slight 0.01%.
Segmental Analysis
The company currently distributes products through subsidiaries — Patterson Dental and Patterson Animal Health.
Dental Segment
This segment provides a virtually complete range of consumable dental products, equipment, software, turnkey digital solutions and value-added services to dentists as well as laboratories throughout North America.
In the second quarter, dental sales (39% of total sales) declined 2% year over year to approximately $542.5 million.
Dental Consumable
Sales in the sub-segment were $303.8 million, down 2.4% year over year.
Dental Equipment & Software
Sales in the segment fell 1.1% on a year-over-year basis to $167.7 million.
Other
This segment comprises technical service, parts and labor, software support services as well as office supplies. Sales in the segment declined 2.6% on a year-over-year basis to $71 million.
Animal Health Segment
This segment is a leading distributor of veterinary supplies to clinics, public and private institutions and shelters across the United States.
Coming to the second-quarter performance of the platform (61% of total sales), sales increased almost 3.9% on a year-over-year basis to $855.4 million.
Corporate
Sales at the segment were $6.83 million, down 19.9% year over year.
Gross Margin Analysis
Gross profit in the reported quarter was $295.1 million, down 6.5% year over year. As a percentage of revenues, gross margin contracted 180 basis points (bps) to 21% in the second quarter.
Operating expenses in the reported quarter totaled $253.9 million, up 4% on a year-over-year basis.
Guidance
For fiscal 2019, Patterson Companies has retained its guidance. Notably, earnings per share are expected in the range of $1.40 to $1.50.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in fresh estimates.
VGM Scores
At this time, Patterson Cos. has a subpar Growth Score of D, however its Momentum Score is doing a lot better with a B. Charting a somewhat similar path, the stock was allocated a grade of A on the value side, putting it in the top 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of this revision indicates a downward shift. Notably, Patterson Cos. has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.